On the determination of plasma prekallikrein with chromogenic peptide substrate
Nakamura, S.; Takizawa, N.; Nakanishi, K.; Igarashi, M.
Rinsho Byori. Japanese Journal of Clinical Pathology 28(7): 670-674
1980
ISSN/ISBN: 0047-1860 PMID: 6906394 Document Number: 163084
Document emailed within 1 workday
Related Documents
Wen-yao Huang; Wan, X.; Zhang, S. 2009: A Novel Chromogenic Peptide for Prekallikrein/Kallikrein Determination Clinical Laboratory 55(3-4): 106-113Oh-ishi, S.; Katori, M. 1979: Fluorometric assay for plasma prekallikrein using peptidymethyl-coumarinyl-amide as a substrate Thrombosis Research 14(4-5): 551-559
Aiach, M.; Michaud, A.; Capron, L.; Fiessinger, J.N. 1982: Determination of factor X and heparin with chromogenic substrate Acta Chirurgica Scandinavica. Supplementum 509: 109-113
Witt, I.; Tritschler, W. 1982: Alpha 1-antitrypsin: reference values in serum and plasma with benzoyl-D,L-arginine-p-nitroanilide, a chromogenic substrate Journal of Clinical Chemistry and Clinical Biochemistry 20(8): 587-591
Dotsenko, V.L.; Iarovaia, G.A.; Paskhina, T.S. 1989: Comparative analysis of methods of determination of kallikrein and prekallikrein in the human plasma (review of the literature) Voprosy Meditsinskoi Khimii 35(6): 13-19
Suzuki, K.; Nishioka, J.; Hashimoto, S. 1980: Assay method of plasma plasminogen by means of a synthetic fluorogenic peptide substrate (3104-V) Rinsho Byori. Japanese Journal of Clinical Pathology 28(8): 804-807
Lanevschi, A.; Kramer, J.W.; Greene, S.A.; Meyers, K.M. 1996: Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs American Journal of Veterinary Research 57(8): 1124-1130
Noto, A.; Ogawa, Y.; Mori, S.; Yoshioka, M.; Kitakaze, T.; Hori, T.; Nakamura, M.; Miyake, T. 1983: Simple, rapid spectrophotometry of urinary N-acetyl-beta-D-glucosaminidase, with use of a new chromogenic substrate Clinical Chemistry 29(10): 1713-1716
Van Voorthuizen, H.; Kluft, C. 1984: Improved assay conditions for automated antithrombin IIi determinations with the chromogenic substrate S-2238 Thrombosis and Haemostasis 52(3): 350-353
Lee, C.; Barrowcliffe, T.; Bray, G.; Gomperts, E.; Hubbard, A.; Kemball-Cook, G.; Lilley, P.; Owens, D.; Von Tilberg, L.; Pasi, J. 1996: Pharmacokinetic in vivo comparison using 1-stage and chromogenic substrate assays with two formulations of Hemofil-M Thrombosis and Haemostasis 76(6): 950-956
Tanaka, O.; Hayashi, S.; Hayashi, S.; Meguro, T.; Yamada, K. 1989: Fundamental examination of measurement of urinary urokinase inhibitor activity using chromogenic substrate Rinsho Byori. Japanese Journal of Clinical Pathology 37(6): 687-691
Sandset, P.M.; Larsen, M.L.; Abildgaard, U.; Lindahl, A.K.; Odegaard, O.R. 1991: Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 2(3): 425-433
Zebrowska-Lupina, I.; Kolber-Postepska, B.; Markiewicz, M.; Horubała-Bielak, G. 1994: Concentrations of kininogen and prekallikrein in plasma and activity of plasma renin depending on the type of blood pressure response to captopril in patients with arterial hypertension Wiadomosci Lekarskie 47(7-8): 241-247
Kutuzov, V.A.; Mikhaĭlov, V.V.; Kruglova, S.E.; Kutuzov, V.V.; Kirillov, A.P.; Krasnianskiĭ, V.P.; Pshenichnov, V.A.; Lebedinskaia, E.V. 1993: A comparative evaluation of an immunoenzyme analytical method using a fluorogenic or chromogenic substrate in determining the Marburg virus antigen Voprosy Virusologii 38(1): 17-18
Hopmeier, P.; Heuss, F.; Fischer, M. 1984: Changes in antithrombin III values during and after extracorporeal circulation in heart surgery, measured on the day of operation using a chromogenic substrate and a laser nephelometer Wiener Klinische Wochenschrift 96(24): 881-884
Martin, P.A.; Gaunnac, G.L.; Tsuji, K. 1986: Automation of microtiter plate-chromogenic substrate LAL endotoxin assay method by use of a modified Cetus Pro/Pette Express system Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 40(2): 61-66
Hiura, H.; Nishiyama, T.; Kimura, M.; Matoba, K.; Hayashi, O.; Sasaki, M.; Ishijima, C.; Irie, Y.; Yasuda, N. 1989: Recent progress on analysis of blood coagulation factors and fibrinolytic agents; new synthetic chromogenic substrate assays for hemostatic parameters Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 81: 214-219
Egberg, N.; Gallimore, M.J. 1983: Studies on Hageman factor, plasma prekallikrein, kallikrein "like" activity and kallikrein inhibition in plasma samples from normal subjects and clinical material Advances in Experimental Medicine and Biology 156: 1109-1117
Khvatov, V.B.; Petrenko, O.A. 1975: Production of a specific substrate-human plasminogen--for the quantitative determination of plasminogen activator in the blood plasma in sudden death Problemy Gematologii i Perelivaniia Krovi 20(6): 57-60
De La Cadena, R.A.; Scott, C.F.; Colman, R.W. 1987: Evaluation of a microassay for human plasma prekallikrein Journal of Laboratory and Clinical Medicine 109(5): 601-607